Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pKM2L-phGCG (#RDB05490)

Promoter Bank clone, Human glucagon promoter

Alternative name p1898-1F
Clone info. PCR amplified human glucagon promoter sequence was inserted into a Renilla luciferase reporter vector pKM2L (RDB04026). Cloned fragment: 162153856 to 162152194(NC_000002.12); relatively -1452 to +211, where +1 corresponds to 1 nt of NM_002054.4.
Comment PCR cloning, forward primer, 1898F-SpeI: 5' gactactagtctagaccgacctaaggcttgacacc 3'; reverse primer, 1898R-SalI: 5' gactgtcgacagagagcaagccctctttgggaac 3'; Entire sequence of promoter region has not been confirmed. Promoter activity has not been analyzed.
Vector backbone pKM2L (RDB04026) (Plasmid)
Size of vector backbone 4.2 kb
Selectable markers Kan^r
Gene/insert name Human glucagon genomic DNA
Depositor|Developer DNA Bank, |
 

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
Please visit Information of Request for Distribution.[link] 
Terms and conditions for distribution 1. The RECIPIENT agrees to use the BIOLOGICAL RESOURCE only for academic research in the non-profit organization. 2. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
Additional terms and conditions:
The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ]
手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件 1. 本件リソースは学術研究機関にのみ提供し、学術研究にのみ利用することができる。 2. 謝辞の表明を必要とする。
MTAに書く付加的使用条件:
本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。

Catalog # Resource name Shipping form Fee (non-profit org.)
RDB05490 pKM2L-phGCG DNA solution JPY 9,460 (not-for-profit academic purpose)
plus cost of shipping containers, dry ice (if required) and shipping charge

Please review the QC test results indicated by check icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

The pKM2L-phGCG was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB05490).

Reference section:

Further references such as user reports and related articles (go to bottom)


QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check icon as well as clone information before placing your order.

Test sheet RDB05490_A6A7p1.pdf check

Nucleotide sequence of a portion of this resource (if available).

Primer: M13_-40
Sequence file: RDB05490_A6A7a.seq check
>05490_05490_A6A7_2_M13(-40)_B10_04.ab1
    1 CGGGGGTCAG CTTGCATGCC TGCAGGTCAT TTAATAGGGA TAACAGGGTA ATGATTAAGA
   61 TCTCGAGCTC TAAGCTTCAC ATATGCATGC ACTAGTCTAG ACCGACCTAA GGCTTGACAC
  121 CTTTCTCTGC TCTTTCACCC CCTCTGCTGG TAGAGTGCCA AGAAGCAGGT CTCAGATCAA
  181 GACACCAGCA GTACCAATGA GGAGATAAAG TGAGGCAGAT ATTTTATGCA GCTGTGCTTC
  241 TCAAATTTTA ATATGAACAC AGATTTCCTT AGGATTTTGT TAAAATACAG ATTCTGATAG
  301 GCACGAGATT CTGCATTTCT AGCAAGCTCC CAGATGATGC TGGTCCTTAG ACCACACTTT
  361 GCAAAGCAAG GCTTTCTAGC ACCCAATAAT CACCAGCACA AAAACCCCTC AATGATGTCT
  421 TCCAGTCTGA CTTGAAAGTG ATCTCTGTGG CCTTCAAGTA GCTCTACATT CAAACGTTGG
  481 TCTCATGCAC AAATTGAACA GTTAAGTTCA TTTGGAATAT TTCTCCAGTT GCCTCAATGA
  541 TTTACCTCCA TACAAGTCAT CAGTGACATC ATGCGGTTGG TTATATTAGA ATATTGGAAT
  601 CTAGTTAGGA AATGTTGTGA TGAGTTTGCA ATATGGAATA AAATTTTTAT TTTAGAAAAG
  661 ACATTTACCA ACCCCTCTCA TTTTACAAAT AAGGAGGCAG AGACACAAAG AGAATGCGTG
  721 ACTTGACCAA GGTCACACAG CTGGTCAATA ACAGCAAAAC TAAAATCAAA TTATGCCAAC
  781 ACTACTTCTT ATGCTGTCTT TCCAGATTAT TTACCATTTT TCTATCTCTC TACAGTGACC
  841 AGAATCATTT CTGCTAAATG TCACAGATCA TTAAAGCCTG TGTGTCCAGT CACAAAACTC
  901 AGGAAACGTG AAAATATGCA TCTCATCTCA ACAGTTTTTC CTCATATCTC ATTCTTTTGT
  961 AAACTTAGTA CCCCCACTCT CTTATCAGTA AAAATTTAGA TTTTTTAAAT ATATATTAGA
 1021 ATGGAAAAAA ATACCCAGAT CATTTCCTGG CTAGCATTCA GCTATTCTTG GCATGCTTTT
1081 AATTCCATCG A
//
Primer: phRLR2
Sequence file: RDB05490_A6A7b.seq check
>05490_05490_A6A7_2_phRLR2_E10_13.ab1
    1 ATCCAGACTC GAAGCCCAGT TTCTATTGGT CTCCTTAACC TGTCTTGTAA CCTTGATACT
   61 TACCTGCCCA GTGCCTCACG ACCAACTTCT GCAGTACCCG GGTGAATTCT ACGCGTCGAC
  121 AGAGAGCAAG CCCTCTTTGG GAACTTTTGA TGTGCTCTGT GTCCTAAGCT CTGTACTTCT
  181 GCACCAAGGC GCACTGCTTT TATATACTCT CCAGCTCTGT TTAGCCTCAC AGATATTACG
  241 CTGACAATAT AAATTTCTCA TCTGTAAATA ATGAGTTTTT GTTACAAATG ACTTCCCTCT
  301 CCCACTCACT TTGCTCATCT GCATTCTATG CTTATATTGG GTGAGAGACC TTAGAGACCT
  361 GGAAACTTTT TATGCACTCT TGTATCTTTT TTTTTTTTTG GTTGGGAATG GAGAGAGCAG
  421 CTTGGAAATC CACCTTCTAC TTTCAATCAC GCATGAAAAT CACTTAAGTT CTCTAAAGTG
  481 AATTTTGACG TTGAAGACAA AAGACCTTGA AATTACGTAG CCCATGGCCA TCCCTGTTTT
  541 GTGCATGTCC TCATTTGAGG TTCTTACAAG TCTTTGGTTT GCTACCTAGC CATGATGAAT
  601 TTACCTGAAT ATAACAATCA CTTCAGTCAT TCATTTATCT AAATAATGAT CATTCATTCA
  661 ACACATATGT ATTAAAAATC CTCTCTTCCT CACAACGTGG AGTTTATTTA TGTTATGTTT
  721 GTGGAAAATT TAAGGATATT GATTAAACCC CTATGTGTTC TGTTTTAATA AATGGAATTC
  781 AGGCAGAAAG GATGGAGCAA AATGAAGATT AAACATCCAA GATAGCTGAT GCTAACAGGA
  841 AATTATCTGG TATTTTTTTC CTTCTAATAT ATATTTAAAA TCTAATTTTA CTGATAAGAG
  901 AGTGGGGTAC TAAGTTACAA AAGAATGAGA TATGAGGAAA ACTGTTTGAG ATGAGATGCA
  961 TATTTTTCAC GTTTCCCTGA GTTTTGTGAC TGGACACACA GGCTTTAAAT GATCTGTGAC
 1021 ATTTAGCCAG AAATTGAATC CTGGTTCACT GTAGAGCATA GCAACAATGC TCAATAAGTC
1081 TGGCAAAAGG ACCAGGCATT AAG
//
Primer: pAxCALNL_F1
Sequence file: RDB05490_A6A7c.seq check
>05490_05490_A6A7_2_pAxCALNL_F1_H10_22.ab1
    1 TAGGTATCTT ATCATGTCTG CTCGAGCGGC CGCTCTAGAA TTACTGCTCG TTCTTCAGCA
   61 CGCGCTCCAC GAAGCTCTTG ATGTACTTAC CCATTTCATC TGGAGCGTCC TCCTGGCTGA
  121 AGTGGAGGCC CTTCACCTTC ACGAACTCGG TGTTAGGGAA CTTCTTAGCT CCCTCGACAA
  181 TAGCGTTGGA AAAGAACCCA GGGTCGGACT CGATGAACAT CTTAGGCAGA TCGTCGCTGG
  241 CCCGAAGGTA GGCGTTGTAG TTGCGGACAA TCTGGACGAC GTCGGGCTTG CCTCCCTTAA
  301 CGAGAGGGAT CTCGCGAGGC CAGGAGAGGG TAGGCCGTCT AACCTCGCCC TTCTCCTTGA
  361 ATGGCTCCAG GTAGGCAGCG AACTCCTCAG GCTCCAGTTT CCGCATGATC TTGCTTGGGA
  421 GCATGGTCTC GACGAAGAAG TTATTCTCAA GCACCATTTT CTCGCCCTCT TCGCTCTTGA
  481 TCAGGGCGAT ATCCTCCTCG ATGTCAGGCC ACTCGTCCCA GGACTCGATC ACGTCCACGA
  541 CACTCTCAGC ATGGACGATG GCCTTGATCT TGTCTTGGTG CTCGTAGGAG TAGTGAAAGG
  601 CCAGACAAGC CCCCCAGTCG TGGCCCACAA AGATGATTTT CTTTGGAAGG TTCAGCAGCT
  661 CGAACCAAGC GGTGAGGTAC TTGTAGTGAT CCAGGAGGCG ATATGAGCCA TTCCCGCTCT
  721 TGCCGGACTT ACCCATTCCG ATCAGATCAG GGATGATGCA TCTAGCCACG GGCTCGATGT
  781 GAGGCACGAC GTGCCTCCAC AGGTAGCTGG AGGCAGCGTT ACCATGCAGA AAAAATCACG
  841 GCGTTCTCGG CGTGCTTCTC GGAATCATAG TAGTTGATGA AGGAGTCCAG CACGTTCATT
  901 TGCTTGCAGC GAGCCCACCC ACTGAGGCCC AGTTGATCAT GCGTTTGCGT TTGCTCGGGG
  961 GTTCGGTACA CCTTTGCAAG CCCATGGTGG CCTTAGCTAT AGTGAGTCGT AATAGGTACT
1021 CTAGCCCTTT AGGAGCTGTA ATGAACTTGG TAGTGACACC T
//

Please visit Sequencing and PCR primers for primer information.


References

Original, user report and related articles